Obesity and type 2 diabetes

Nutrition Bulletin

Volumn 31, Issue 2, 2006, Pages 111-114

  Waine, Colin ^a  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

Author keywords

cell toxicity; Abdominal obesity; Adipokines; Cardiometabolic risk; Insulin resistance; Type 2 diabetes

Indexed keywords

ADIPONECTIN; INSULIN; RIMONABANT; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TUMOR NECROSIS FACTOR ALPHA;

BEHAVIOR MODIFICATION; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASE; DRUG RESEARCH; GOVERNMENT; HEALTH PROGRAM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LICENSING; LIFESTYLE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PATHOGENESIS; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK REDUCTION; WEIGHT REDUCTION;

EID: 33744496333     PISSN: 14719827     EISSN: 14673010     Source Type: Journal    
DOI: 10.1111/j.1467-3010.2006.00563.x     Document Type: Review

References (21)

1. Arner P (2005) Insulin resistance in type 2 diabetes - role of the adipokines. Current Molecular Medicine 5: 333-9.
2. Bacha F, Saad R, Gungor N et al. (2004) Adiponectin in youth. Relationship to visceral adiposity, insulin sensitivity and beta cell function. Diabetes Care 27: 547-52.
3. Després JP, Lemieux I & Prud'homme D (2001) Treatment of obesity: Need to focus on high risk abdominally obese patients. British Medical Journal 322: 716-20.
4. Diabetes UK (2000) Fact Sheet 2. Diabetes. Diabetes UK: London.
5. Fasshauer M & Paschke R (2003) Regulation of adipocytokines and insulin resistance. Diabetologia 46: 1594-603.
6. Han TS, van Leer EM, Seidell JC et al. (1995) Waist circumference action levels in the identification of cardiovascular risk factors: Prevalence study in a random sample. British Medical Journal 311: 1401-5.
7. Hayden MR & Tyagi SC (2002) Islet redox stress: The manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus. Journal of the Pancreas 3: 86-108.
8. Hayden MR & Tyagi SC (2002) Intimal redox stress: Accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy. Cardiovascular Diabetology 1: Accessed online.
9. Hull RL, Westermark GT, Westermark P et al. (2004) Islet amyloid: A critical entity in the pathogenesis of type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 89: 3629-43.
10. Mohamed-Ali V & Coppack S (2005) Adipose tissue-derived factors. In: Cardiovascular Disease: Diet, Nutrition and Emerging Risk Factors. The Report of the British Nutrition Foundation (2005) (S Stanner ed.). Blackwell Publishing: Oxford.
11. Pouliot MC, Després JP, Lemieux S et al. (1994) Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. American Journal of Cardiology 73: 460-8.
12. Ritchie SA, Ewart MA, Perry CG et al. (2004) The role of insulin and the adipocytokines in regulation of vascular endothelial function. Clinical Science (London) 107: 519-32.
13. Stumvoll M, Goldstein BJ & van Haeften TW (2005) Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365: 1333-46.
14. Trayhurn P (2005) The biology of obesity. Proceeding of the Nutrition Society 64: 31-8.
15. Van Gaal LF, Rissanen AM, Scheen AJ et al. (2005) Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365: 1389-97.
16. Wahrenberg H, Hertel K, Leijonhufvud BM et al. (2005) Use of waist circumference to predict insulin resistance: Retrospective study. British Medical Journal 330: 1363-4.
17. Weir GC & Bonner-Weir S (2004) Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53: S16-S21.
18. WHO (World Health Organization) (2003) Obesity and Overweight. Available at: http://www.who.int/dietphysicalactivity/publications/facts/obesity/ en/.
19. WHO (World Health Organization) (2004) Diabetes Programme. Country and Regional Data. Available at: http://www.who.int/diabets/facts/ world_figures/en/.
20. Yusuf S, Hawken S, Ounpuu S et al. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 364: 937-52.
21. Zhao YF, Feng DD & Chen C (2006) Contribution of adipocyte-derived factors to beta-cell dysfunction in diabetes. International Journal of Biochemistry and Cell Biology 38: 804-19.